Analyst rating sparks interest: Recent coverage from Wedbush has highlighted Infleqtion's potential in quantum technologies, with a price target suggesting notable upside. Social media participants note the firm's existing revenue streams and partnerships with entities like NASA as key strengths. Discussions emphasize execution on scaling logical qubits as a pivotal factor ahead.
Price action draws scrutiny: The stock has been consolidating in a defined trading range, prompting commentary on its current valuation relative to peers in the quantum sector. Observers point to product sales and a dedicated team as reasons for sustained interest despite recent volatility. Some express optimism that near-term milestones could drive re-rating by year-end.
Long-term outlook debated: Broader conversations focus on Infleqtion's room-temperature operations and government ties as differentiators in a competitive field. Participants share views on holding through fluctuations, citing the company's progress toward commercial applications. Overall exchanges reflect measured expectations tied to technological advancements.
Note: This discussion summary was generated from an AI condensation of post data.
Infleqtion Insider Trading Activity
Infleqtion insiders have traded $INFQ stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.
Here’s a breakdown of recent trading of $INFQ stock by insiders over the last 6 months:
- CAPITAL LTD MAVERICK has made 0 purchases and 23 sales selling 13,705,267 shares for an estimated $214,945,729.
- DAVID B SINGER has made 0 purchases and 18 sales selling 13,416,767 shares for an estimated $210,534,930.
- MATTHEW JOHN KINSELLA (Chief Executive Officer) has made 0 purchases and 5 sales selling 769,954 shares for an estimated $13,115,941.
- PRANAV GOKHALE (Chief Technology Officer) sold 120,000 shares for an estimated $2,127,600
- PAUL LIPMAN (Chief Revenue Officer) sold 100,000 shares for an estimated $1,583,000
- KRISTINA M JOHNSON has made 0 purchases and 2 sales selling 50,000 shares for an estimated $853,500.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Infleqtion Hedge Fund Activity
We have seen 84 institutional investors add shares of Infleqtion stock to their portfolio, and 0 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MAVERICK CAPITAL LTD added 19,941,924 shares (+inf%) to their portfolio in Q1 2026, for an estimated $195,630,274
- ALYESKA INVESTMENT GROUP, L.P. added 5,000,000 shares (+inf%) to their portfolio in Q1 2026, for an estimated $49,050,000
- CITADEL ADVISORS LLC added 2,392,625 shares (+inf%) to their portfolio in Q1 2026, for an estimated $23,471,651
- QVT FINANCIAL LP added 1,254,220 shares (+inf%) to their portfolio in Q1 2026, for an estimated $12,303,898
- OPPENHEIMER & CO INC added 838,209 shares (+inf%) to their portfolio in Q1 2026, for an estimated $8,222,830
- GOLDMAN SACHS GROUP INC added 679,819 shares (+inf%) to their portfolio in Q1 2026, for an estimated $6,669,024
- UBS GROUP AG added 632,001 shares (+inf%) to their portfolio in Q1 2026, for an estimated $6,199,929
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Infleqtion Price Targets
Multiple analysts have issued price targets for $INFQ recently. We have seen 2 analysts offer price targets for $INFQ in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Antoine Legault from Wedbush set a target price of $20.0 on 06/26/2026
- Atif Malik from Citigroup set a target price of $20.0 on 04/14/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
